Appointments Jobs About Search Education & Research Clinical Trials Health Information Medical Services

Publications - Vijayalakshmi Shridhar, Ph.D.

Back to Research Profile

  1. Rattan R, Giri S, Hartmann L, Shridhar V. Metformin attenuates ovarian cancer cell growth in an AMP- kinase dispensable manner. J Cell Mol Med 2009 Oct 29. [Epub ahead of print]
    View PubMed
  2. Tomshine JC, Severson SR, Wigle DA, Sun Z, Beleford DA, Shridhar V, Horazdovsky BF. Cell proliferation and epidermal growth factor signaling in non-small cell lung adenocarcinoma cell lines are dependent on Rin1. J Biol Chem 2009 Sep 25; 284(39):26331-9. Epub 2009 Jul 01.
    View PubMed
  3. Chien J, Ota T, Aletti G, Shridhar R, Boccellino M, Quagliuolo L, Baldi A, Shridhar V. Serine protease HtrA1 associates with microtubules and inhibits cell migration. Mol Cell Biol 2009 Aug; 29(15):4177-87. Epub 2009 May 26.
    View PubMed
  4. Peedicayil A, Vierkant RA, Shridhar V, Schildkraut JM, Armasu S, Hartmann LC, Fridley BL, Cunningham JM, Phelan CM, Sellers TA, Goode EL. Polymorphisms in TCEAL7 and risk of epithelial ovarian cancer. Gynecol Oncol 2009 Aug; 114(2):260-4. Epub 2009 May 05.
    View PubMed
  5. Chien J, Ota T, Aletti G, Shridhar R, Boccellino M, Quagliuolo L, Baldi A, Shridhar V. Serine protease HtrA1 associates with microtubules and inhibits cell migration. Mol Cell Biol 2009 Aug; 29(15):4177-87.
    View PubMed
  6. Chien J, Fan JB, Bell DA, April C, Klotzle B, Ota T, Lingle WL, Gonzalez Bosquet J, Shridhar V, Hartmann LC. Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer. Gynecol Oncol 2009 Jul; 114(1):3-11. Epub 2009 May 01.
    View PubMed
  7. Liu P, Khurana A, Rattan R, He X, Kalloger S, Dowdy S, Gilks B, Shridhar V. Regulation of HSulf-1 expression by variant hepatic nuclear factor 1 in ovarian cancer. Cancer Res 2009 Jun 1; 69(11):4843-50.
    View PubMed
  8. Chien J, Campioni M, Shridhar V, Baldi A. HtrA serine proteases as potential therapeutic targets in cancer. Curr Cancer Drug Targets 2009 Jun; 9(4):451-68.
    View PubMed
  9. Lai JP, Sandhu DS, Moser CD, Cazanave SC, Oseini AM, Shire AM, Shridhar V, Sanderson SO, Roberts LR. Additive effect of apicidin and doxorubicin in sulfatase 1 expressing hepatocellular carcinoma in vitro and in vivo. J Hepatol 2009 Jun; 50(6):1112-21. Epub 2009 Mar 09.
    View PubMed
  10. Chien J, He X, Shridhar V. Identification of tubulins as substrates of serine protease HtrA1 by mixture-based oriented peptide library screening. J Cell Biochem 2009 May 15; 107(2):253-63.
    View PubMed
  11. Chien J, Narita K, Rattan R, Giri S, Shridhar R, Staub J, Beleford D, Lai J, Roberts LR, Molina J, Kaufmann SH, Prendergast GC, Shridhar V. A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation. Oncogene 2008 Dec 11; 27(58):7223-34. Epub 2008 Sep 22.
    View PubMed
  12. Bhattacharya R, Kwon J, Ali B, Wang E, Patra S, Shridhar V, Mukherjee P. Role of hedgehog signaling in ovarian cancer. Clin Cancer Res 2008 Dec 1; 14(23):7659-66.
    View PubMed
  13. Ajayi F, Kongoasa N, Gaffey T, Asmann YW, Watson WJ, Baldi A, Lala P, Shridhar V, Brost B, Chien J. Elevated expression of serine protease HtrA1 in preeclampsia and its role in trophoblast cell migration and invasion. Am J Obstet Gynecol 2008 Nov; 199(5):557.e1-10. Epub 2008 Jul 29.
    View PubMed
  14. Baldi A, Mottolese M, Vincenzi B, Campioni M, Mellone P, Di Marino M, di Crescenzo VG, Visca P, Menegozzo S, Spugnini EP, Citro G, Ceribelli A, Mirri A, Chien J, Shridhar V, Ehrmann M, Santini M, Facciolo F. The serine protease HtrA1 is a novel prognostic factor for human mesothelioma. Pharmacogenomics 2008 Aug; 9(8):1069-77.
    View PubMed
  15. Baldi A, Mottolese M, Vincenzi B, Campioni M, Mellone P, Di Marino M, di Crescenzo VG, Visca P, Menegozzo S, Spugnini EP, Citro G, Ceribelli A, Mirri A, Chien J, Shridhar V, Ehrmann M, Santini M, Facciolo F. The serine protease HtrA1 is a novel prognostic factor for human mesothelioma. Pharmacogenomics 2008 Aug; 9(8):1069-77.
    View PubMed
  16. Ajayi F, Congosoa N, Gaffey T, Asmann YW, Watson W, Baldi A, Lala P, Shridhar V, Brost B, Chien J. Aberrant expression of HtrA1 in preeclampsia. Am J Obstet Gynecol 2008 July 28:in press.
    View PubMed
  17. Chien J, Rattan R, Narita K, Giri S, Shridhar R, Staub J, Beleford D, Lai J, Molina J, Kaufmann SH, Prendergast GC, Shridhar V. Candidate tumor suppressor gene TCEAL7 negatively regulates c-Myc. Oncogene 2008:in press.
    View PubMed
  18. Chien J, Campioni M, Shridhar V, Baldi A. HtrA Serine Proteases as Potential Therapeutic Targets in Cancer. Current Cancer Drug Targets 2008:in press.
    View PubMed
  19. Bhattacharya R, Kwon J, Ali B, Wang E, Patra S, Shridhar V, Mukherjee P. Role of hedgehog signaling in ovarian cancer. Clin Can Res 2008:in press.
    View PubMed
  20. Chien JR, Aletti G, Bell DA, Keeney GL, Shridhar V, Hartmann LC. Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer. J Cell Biochem 2007 Dec 1; 102(5):1117-29.
    View PubMed
  21. Staub J, Chien J, Pan Y, Qian X, Narita K, Aletti G, Scheerer M, Roberts LR, Molina J, Shridhar V. Epigenetic silencing of HSulf-1 in ovarian cancer:implications in chemoresistance. Oncogene 2007 Jul 26; 26(34):4969-78. Epub 2007 Feb 19.
    View PubMed
  22. Narita K, Chien J, Mullany SA, Staub J, Qian X, Lingle WL, Shridhar V. Loss of HSulf-1 expression enhances autocrine signaling mediated by amphiregulin in breast cancer. J Biol Chem 2007 May 11; 282(19):14413-20.
    View PubMed
  23. Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, Chen H, Zhao Y, Pearson E, Li X, Chien J, Dewan A, Harmon J, Bernstein PS, Shridhar V, Zabriskie NA, Hoh J, Howes K, Zhang K. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006 Nov 10; 314(5801):992-3. Epub 2006 Oct 19.
    View PubMed
  24. Wang X, Wang F, Taniguchi K, Seelan RS, Wang L, Zarfas KE, McDonnell SK, Qian C, Pan K, Lu Y, Shridhar V, Couch FJ, Tindall DJ, Beebe-Dimmer JL, Cooney KA, Isaacs WB, Jacobsen SJ, Schaid DJ, Thibodeau SN, Liu W. Truncating variants in p53AIP1 disrupting DNA damage-induced apoptosis are associated with prostate cancer risk. Cancer Res 2006 Nov 1; 66(21):10302-7.
    View PubMed
  25. Spugnini EP, Cardillo I, Verdina A, Crispi S, Saviozzi S, Calogero R, Nebbioso A, Altucci L, Cortese G, Galati R, Chien J, Shridhar V, Vincenzi B, Citro G, Cognetti F, Sacchi A, Baldi A. Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma. Clin Cancer Res 2006 Oct 15; 12(20 Pt 1):6133-43.
    View PubMed
  26. Wang X, Zheng L, Zeng Z, Zhou G, Chien J, Qian C, Vasmatzis G, Shridhar V, Chen L, Liu W. DIXDC1 isoform, l-DIXDC1, is a novel filamentous actin-binding protein. Biochem Biophys Res Commun 2006 Aug 18; 347(1):22-30. Epub 2006 Jun 19.
    View PubMed
  27. Chien J, Aletti G, Baldi A, Catalano V, Muretto P, Keeney GL, Kalli KR, Staub J, Ehrmann M, Cliby WA, Lee YK, Bible KC, Hartmann LC, Kaufmann SH, Shridhar V. Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity. J Clin Invest 2006 Jul; 116(7):1994-2004. Epub 2006 Jun 08.
    View PubMed
  28. Narita K, Staub J, Chien J, Meyer K, Bauer M, Friedl A, Ramakrishnan S, Shridhar V. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo. Cancer Res 2006 Jun 15; 66(12):6025-32.
    View PubMed
  29. Lai JP, Yu C, Moser CD, Aderca I, Han T, Garvey TD, Murphy LM, Garrity-Park MM, Shridhar V, Adjei AA, Roberts LR. SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma. Gastroenterology 2006 Jun; 130(7):2130-44.
    View PubMed
  30. Dowdy SC, Gostout BS, Shridhar V, Wu X, Smith DI, Podratz KC, Jiang SW. Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines. Gynecol Oncol 2005 Oct; 99(1):126-34.
    View PubMed
  31. Lewis KA, Mullany S, Thomas B, Chien J, Loewen R, Shridhar V, Cliby WA. Heterozygous ATR mutations in mismatch repair-deficient cancer cells have functional significance. Cancer Res 2005 Aug 15; 65(16):7091-5.
    View PubMed
  32. Chien J, Staub J, Avula R, Zhang H, Liu W, Hartmann LC, Kaufmann SH, Smith DI, Shridhar V. Epigenetic silencing of TCEAL7 (Bex4) in ovarian cancer. Oncogene 2005 Jul 28; 24(32):5089-100.
    View PubMed
  33. Ward R, Johnson M, Shridhar V, van Deursen J, Couch FJ. CBP truncating mutations in ovarian cancer. J Med Genet 2005 Jun; 42(6):514-8.
    View PubMed
  34. Grau S, Baldi A, Bussani R, Tian XD, Stefanescu R, Przybylski M, Richards P, Jones SA, Shridhar V, Clausen T, Ehrmann M. Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proc Natl Acad Sci U S A 2005 Apr 26; 102(17):6021-6.
    View PubMed
  35. Hartmann LC, Lu KH, Linette GP, Cliby WA, Kalli KR, Gershenson D, Bast RC, Stec J, Iartchouk N, Smith DI, Ross JS, Hoersch S, Shridhar V, Lillie J, Kaufmann SH, Clark EA, Damokosh AI. Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy. Clin Cancer Res 2005 Mar 15; 11(6):2149-55.
    View PubMed
  36. De Luca A, De Falco M, De Luca L, Penta R, Shridhar V, Baldi F, Campioni M, Paggi MG, Baldi A. Pattern of expression of HtrA1 during mouse development. J Histochem Cytochem 2004 Dec; 52(12):1609-17.
    View PubMed
  37. Wang F, Denison S, Lai JP, Philips LA, Montoya D, Kock N, Schule B, Klein C, Shridhar V, Roberts LR, Smith DI. Parkin gene alterations in hepatocellular carcinoma. Genes, Chromosomes & Cancer 2004 Jun; 40(2):85-96.
    View PubMed
  38. Chien J, Staub J, Hu SI, Erickson-Johnson MR, Couch FJ, Smith DI, Crowl RM, Kaufmann SH, Shridhar V. A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer. Oncogene 2004 Feb 26; 23(8):1636-44.
    View PubMed
  39. Lai JP, Chien J, Strome SE, Staub J, Montoya DP, Greene EL, Smith DI, Roberts LR, Shridhar V. HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma. Oncogene 2004 Feb 19; 23(7):1439-47.
    View PubMed
  40. Lai JP, Chien JR, Moser DR, Staub JK, Aderca I, Montoya DP, Matthews TA, Nagorney DM, Cunningham JM, Smith DI, Greene EL, Shridhar V, Roberts LR. hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling. Gastroenterology 2004 Jan; 126(1):231-48.
    View PubMed
  41. Lai J, Chien J, Staub J, Avula R, Greene EL, Matthews TA, Smith DI, Kaufmann SH, Roberts LR, Shridhar V. Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer. J Biol Chem 2003 Jun 20; 278(25):23107-17. Epub 2003 Apr 09.
    View PubMed
  42. Petrova P, Raibekas A, Pevsner J, Vigo N, Anafi M, Moore MK, Peaire AE, Shridhar V, Smith DI, Kelly J, Durocher Y, Commissiong JW. MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons. J Mol Neurosci 2003 Apr; 20(2):173-88.
    View PubMed
  43. Callahan G, Denison SR, Phillips LA, Shridhar V, Smith DI. Characterization of the common fragile site FRA9E and its potential role in ovarian cancer. Oncogene 2003 Jan 30; 22(4):590-601.
    View PubMed
  44. Denison SR, Becker NA, Ferber MJ, Phillips LA, Kalli KR, Lee J, Lillie J, Smith DI, Shridhar V. Transcriptional profiling reveals that several common fragile-site genes are downregulated in ovarian cancer. Genes Chromosomes Cancer 2002 Aug; 34(4):406-15.
    View PubMed
  45. Shridhar V, Sen A, Chien J, Staub J, Avula R, Kovats S, Lee J, Lillie J, Smith DI. Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization. Cancer Res 2002 Jan 1; 62(1):262-70.
    View PubMed
  46. Bast RC Jr, Urban N, Shridhar V, Smith D, Zhang Z, Skates S, Lu K, Liu J, Fishman D, Mills G. Early detection of ovarian cancer: promise and reality. Cancer Treatment Res 2002; 107:61-97.
  47. Shridhar V, Lee J, Pandita A, Iturria S, Avula R, Staub J, Morrissey M, Calhoun E, Sen A, Kalli K, Keeney G, Roche P, Cliby W, Lu K, Schmandt R, Mills GB, Bast RC Jr, James CD, Couch FJ, Hartmann LC, Lillie J, Smith DI. Genetic analysis of early- versus late-stage ovarian tumors. Cancer Res 2001 Aug 1; 61(15):5895-904.
    View PubMed
  48. Shridhar V, Bible KC, Staub J, Avula R, Lee YK, Kalli K, Huang H, Hartmann LC, Kaufmann SH, Smith DI. Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer. Cancer Res 2001 May 15; 61(10):4258-65.
    View PubMed
  49. Acquati F, Morelli C, Cinquetti R, Bianchi MG, Porrini D, Varesco L, Gismondi V, Rocchetti R, Talevi S, Possati L, Magnanini C, Tibiletti MG, Bernasconi B, Daidone MG, Shridhar V, Smith DI, Negrini M, Barbanti-Brodano G, Taramelli R. Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27. Oncogene 2001 Feb 22; 20(8):980-8.
    View PubMed
  50. Kawakami M, Staub J, Cliby W, Hartmann L, Smith DI, Shridhar V. Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer. Int J Oncol 1999 Oct; 15(4):715-20.
    View PubMed
  51. Shridhar V, Staub J, Huntley B, Cliby W, Jenkins R, Pass HI, Hartmann L, Smith DI. A novel region of deletion on chromosome 6q23.3 spanning less than 500 Kb in high grade invasive epithelial ovarian cancer. Oncogene 1999 Jul 1; 18(26):3913-8.
    View PubMed
  52. Huang H, Reed CP, Zhang JS, Shridhar V, Wang L, Smith DI. Carboxypeptidase A3 (CPA3): a novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells. Cancer Res 1999 Jun 15; 59(12):2981-8.
    View PubMed
  53. Huang H, Reed CP, Mordi A, Lomberk G, Wang L, Shridhar V, Hartmann L, Jenkins R, Smith DI. Frequent deletions within FRA7G at 7q31.2 in invasive epithelial ovarian cancer. Genes Chromosomes Cancer 1999 Jan; 24(1):48-55.
    View PubMed
  54. Jett JR, Halling AC, Tazelaar H, Edell E, Midthun D, Marks R, Sloan J, Hillman S, Swensen S, Hartman T, Shridhar V, Smith D. Screening for lung cancer. Pilot study of spiral CT chest scan and sputum cytology. Am J Respir Crit Care Med 1999; 159(Part 2 of 2):A13.
  55. Shridhar V, Jett JR, Smith DI. Molecular advances in the biology of premalignant lesions of lung cancer. Respiratory Care Matters 1999; 3:14-5.
  56. Ohta Y, Shridhar V, Bright RK, Kalemkerian GP, Du W, Carbone M, Watanabe Y, Pass HI. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. Br J Cancer 1999; 81:54-61.
    View PubMed
  57. Ohta Y, Shridhar V, Kalemkerian GP, Bright RK, Watanabe Y, Pass HI. Thrombospondin-1 expression and clinical implications in malignant pleural mesothelioma. Cancer 1999; 85:2570-6.
    View PubMed
  58. Zhang JS, Nelson M, Wang L, Liu W, Qian CP, Shridhar V, Urrutia R, Smith DI. Identification and chromosomal localization of CTNNAL1, a novel protein homologous to alpha-catenin. Genomics 1998 Nov 15; 54(1):149-54.
    View PubMed
  59. Willett CG, Wang MH, Emanuel RL, Graham SA, Smith DI, Shridhar V, Sugarbaker DJ, Sunday ME. Macrophage-stimulating protein and its receptor in non-small-cell lung tumors: induction of receptor tyrosine phosphorylation and cell migration. American Journal of Respiratory Cell & Molecular Biology 1998 Apr; 18(4):489-96.
    View PubMed
  60. Shridhar V, Sun QC, Miller OJ, Kalemkerian GP, Petros J, Smith DI. Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas. Oncogene 1997 Nov 27; 15(22):2727-33.
    View PubMed
  61. Erdmann J, Shimron-Abarbanell D, Shridhar V, Smith DI, Propping P, Nothen MM. Assignment of the human serotonin 1F receptor gene (HTR1F) to the short arm of chromosome 3 (3p13-p14.1). Mol Membr Biol 1997 Jul-Sep; 14(3):133-5.
    View PubMed
  62. Willett CG, Smith DI, Shridhar V, Wang MH, Emanuel RL, Patidar K, Graham SA, Zhang F, Hatch V, Sugarbaker DJ, Sunday ME. Differential screening of a human chromosome 3 library identifies hepatocyte growth factor-like/macrophage-stimulating protein and its receptor in injured lung. Possible implications for neuroendocrine cell survival. J Clin Invest 1997 Jun 15; 99(12):2979-91.
    View PubMed
  63. Shridhar V, Rivard S, Wang X, Shridhar R, Paisley C, Mullins C, Beirnat L, Dugan M, Sarkar F, Miller OJ, Vaitkevicius VK, Smith DI. Mutations in the arginine-rich protein gene (ARP) in pancreatic cancer. Oncogene 1997 May 8; 14(18):2213-6.
    View PubMed
  64. Shridhar V, Wang L, Rosati R, Paradee W, Shridhar R, Mullins C, Sakr W, Grignon D, Miller OJ, Sun QC, Petros J, Smith DI. Frequent breakpoints in the region surrounding FRA3B in sporadic renal cell carcinomas. Oncogene 1997 Mar 20; 14(11):1269-77.
    View PubMed
  65. Carbone M, Rizzo P, Grimley PM, Procopio A, Mew DJY, de Bartlomeis A, Esposito V, Shridhar V, Giuliano MT, Steinberg SM, Levine AS, Giordano A, Pass HI. Simian virus-40 large T-antigen binds p53 in human mesotheliomas. Nature Medicine 1997; 3(8):908-12.
    View PubMed
  66. Shridhar R, Shridhar V, Rivard S, Siegfried JM, Pietraszkiewicz H, Ensley J, Pauley R, Grignon D, Sakr W, Miller OJ, Smith DI. Mutations in the arginine-rich protein gene, in lung, breast, and prostate cancers, and in squamous cell carcinoma of the head and neck. Cancer Res 1996 Dec 15; 56(24):5576-8.
    View PubMed
  67. Shridhar V, Rivard S, Shridhar R, Mullins C, Bostick L, Sakr W, Grignon D, Miller OJ, Smith DI. A gene from human chromosomal band 3p21.1 encodes a highly conserved arginine-rich protein and is mutated in renal cell carcinomas. Oncogene 1996 May 2; 12(9):1931-9.
    View PubMed
  68. Shridhar R, Shridhar V, Wang X, Paradee W, Dugan M, Sarkar F, Glover TW, Vaitkevicius, Smith DI. Frequent breakpoints in the 3p14. 2 fragile site FRA3B, in pancreatic tumors Cancer Res 1996; 6:4347-50.
  69. Shridhar V, Golembieski W, Kamat A, Smith SE, Phillips N, Miller OJ, Miller Y, Smith DI. Isolation of two contigs of overlapping cosmids derived from human chromosomal band 3p21.1 and identification of 5 new 3p21.1 genes. Somat Cell Mol Genet 1994 Jul; 20(4):255-65.
    View PubMed
  70. Shridhar V, Siegfried J, Hunt J, del Mar Alonso M, Smith DI. Genetic instability of microsatellite sequences in many non-small cell lung carcinomas. Cancer Res 1994 Apr 15; 54(8):2084-7.
    View PubMed
  71. Smith SE, Joseph A, Nadeau S, Shridhar V, Gemmill R, Drabkin H, Knuutila S, Smith DI. Cloning and characterization of the human t(3;6)(p14;p11) translocation breakpoint associated with hematologic malignancies. Cancer Genet Cytogenet 1993 Nov; 71(1):15-21.
    View PubMed
  72. Liu W, Piechocki M, Shridhar V, Lyles G, Song Z, Nakamura Y, Drabkin H, Vance J, Smith DI. The isolation of a yeast artificial chromosome (YAC) contig extending for 2 megabases in the vicinity of the von Hippel Lindau disease gene. Hum Mol Genet 1993 Aug; 2(8):1177-82.
    View PubMed
  73. Baldini A, Reid T, Shridhar V, Ogura K, Aiutu DL, Rocchi M, Ward DC. An alphoid DNA sequence is conserved in all human and great ape chromosomes: evidence for ancient centromeric sequences at human chromosomal regions 2q21 and 9q1. Human Genet 1993; 90:577-83.
  74. Ginzinger DG, Shridhar V, Baldini A, Taggart RT, Miller OJ, Smith DI. The human loci DNF15S2 and D3S94 have a high degree of sequence similarity to acyl-peptide hydrolase and are located at 3p21.3. Am J Hum Genet 1992 Apr; 50(4):826-33.
    View PubMed
  75. Baldini A, Archidiacono N, Carbone R, Bolino A, Shridhar V, Miller OJ, Miller DA, Ward D, Rocchi M. Isolation and comparative mapping of a human chromosome 20-specific satellite DNA clone. Cytogenet Cell Genet 1992; 59:12-6.
    View PubMed
  76. Golembieski WA, Smith SE, Recchia F, Judge A, Shridhar V, Miller OJ, Drabkin H, Smith DI. Isolation of large numbers of chromosome 3-specific cosmids containing clusters of rare restriction-endonuclease sites. Am J Hum Genet 1991 Sep; 49(3):581-9.
    View PubMed
  77. Baldini A, Miller DA, Shridhar V, Rocchi M, Miller OJ, Ward D. Comparative mapping of a gorilla-derived alpha satellite DNA clone on great ape and human chromosome. Chromosoma 1991; 101:109-14.
    View PubMed
  78. Warner AH, Shridhar V. Purification and characterization of a cytosol protease from dormant cysts of Artemia, the brine shrimp. J Biol Chem 1985; 260:7008-14.
    View PubMed
  79. Warner AH, Shridhar V. Control of expression of acid protease activity in Artemia embryos. Fed Proc 1982; 41:763.
  80. Warner AH, Shridhar V. Protease activation in Artemia embryos. Can Fed Biol Proc 1980; 23:61.
  81. Warner AH, Shridhar V, Yablonka-Reuvenia Z. Partial characterization of a protein synthesis inhibitor from dormant cysts of Brine shrimp. Can Fed Biol Proc 1978; 21:62.
  82. Warner AH, Thomas DD, Shridhar V, McCurdy HD. The diguanosine nucleotides: Do they exist in fungi? Can J Biochem 1977; 55:841-6.
    View PubMed
  83. Warner AH, Shridhar V, Finamore FJ. Isolation and partial characterization of protein synthesis inhibitor from brine-shrimp embryos. Can J Biochem 1977; 55:965-74.
    View PubMed
  84. Shridhar V, Pillay DTN. Changes in leucyl-tRNAs and animoacyl tRNA synthetases in developing and aging soybean cotyledons. Phytochemistry 1976; 15:1809-12.


Appointments Contact Us Make A Gift Search

Legal restrictions and terms of use applicable to this site

Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.